AzTrials
AzTrials

Multiple SclerosisNCT04057066

Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis (Feasibility Study)

A study testing Physical activity counseling and Exercise in people with Multiple Sclerosis, run by University of Erlangen-Nürnberg at 3 sites in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the feasibility of a 12-week internet-based exercise and physical activity counseling intervention for people with Multiple Sclerosis (MS). Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Multiple Sclerosis
What is being tested?
Physical activity counseling and Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
3 sitesGermany
Study dates
28 Feb 2019to 16 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • diagnosed Multiple Sclerosis (McDonald criteria)
  • expanded Disability Status Scale between 0 - 6.5
  • neurologically stable (no exacerbation within 30 days prior to enrollment)
  • internet access (WiFi)
  • basic knowledge on handling personal computer and the internet
  • owning a smartphone with the operating system Android or IOS and with access to Google Play Store or Apple App score
  • ability to read, write and comprehend as well as communicate electronically
  • not regularly physically active (more than 30 minutes twice a week with a moderate intensity (includes aerobic training, resistance training and other sports e.g. Tennis; excludes physiotherapy, physical activity during work or household, grocery shopping, gardening, walking the dog etc.)

Who cannot join

  • clinically relevant cardiovascular diseases
  • cortisone therapy in the last 30 days
  • cognitive impairment
  • severe impairment of hand function (ataxia or paresis impeding the use of a smartphone app or smartwatch)
  • severe internal, orthopaedic and metabolic diseases that restrict mobility

Trial locations and contacts

3 sites in 1 country.

Germany3 sites
  • Neurological Rehabilitation Center Quellenhof

    Bad Wildbad, Baden-Wurttemberg, 75323

  • Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

    Erlangen

  • Klinikum Würzburg Mitte gGmbH

    Würzburg, Bavaria, 97070

Other trials in Germany

About this study

Official title: Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis. A Feasibility Study.

This study evaluates the feasibility of a 12-week internet-based exercise and physical activity counseling intervention for people with Multiple Sclerosis (MS).

Read the detailed description

Due to high inactivity rates in persons with Multiple Sclerosis (pwMS) physical activity promotion for this target group is needed. The internet is an attractive and feasible medium for physical activity promotion, however interventions have to be adapted to the special needs of pwMS. This study aims to evaluate the feasibility of a 12-week internet-based exercise and physical activity counseling intervention.

26 pwMS will be enrolled in the study. All of them receive the intervention. Focus groups and interviews will be conducted with participating pwMS to determine acceptability of the intervention and to explore participants experiences. Compliance with the intervention will be monitored. Additionally, changes in objective physical activity, subjective physical activity, fatigue, walking ability and level of depression will be calculated.

Being tested
Physical activity counseling, Exercise
Keywords
multiple sclerosis, e-health, physical activity promotion, exercise, feasibility, online, internet based
Medical subject headings
Multiple Sclerosis, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical activity counselingBehavioural

    Physical activity counseling consists of two phone or video calls with a therapists, two group video calls with a therapist and a complementary e-learning course.

  • ExerciseBehavioural

    Participants will agree with their therapist on an exercise plan (endurance and resistance training) that will be made available through the studies mobile app. Frequency and duration of endurance and strength training shall be prescribed in accordance with exercise guidelines for pwMS. However, they can be adjusted according to participants prior physical activity level and their available time slots for exercise during the week.

Study groups in NCT04057066
Study groupRoleWhat they receive
InterventionExperimentalParticipants receive physical activity counseling as well as an individualized exercise plan.
Receives: Behavioral: Physical activity counseling; Behavioral: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability of the Intervention and participants' experiences (focus groups)

    Focus groups (1,5 hrs) with participants to determine extent to which they perceived intervention as appropriate.

    Measured: 1 week after the end of the intervention

  2. Compliance with intervention protocol (completed training sessions and e-learning modules)

    Completed training sessions and e-learning modules will be documented for each participant with the interventions mobile app and e-learning course.

    Measured: over the 12 weeks of intervention

  3. Acceptability of the Intervention and participants' experiences (interviews)

    With those participants that cannot take part in the focus groups, semistructured interviews (30 min) will be conducted to determine extent to which participants' perceived intervention as appropriate. Interview questions are based on focus group questions. The wording is slightly adapted to fit the interview situation.

    Measured: 1 week after the end of the intervention

Secondary outcomes (5)
  1. Changes in objectively measures physical activity

    The physical activity level of participants is measured over a 7 day period with the accelerometer Actigraph GT3X+. The Actigraph GT3X+ measures acceleration on three axes. Steps per day, physical activity per day (activity counts) and time in moderate and vigorous physical activity per day will be calculated.

    Measured: 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)

  2. Changes in subjectively measured physical activity: European Health Interview Survey-Physical Activity Questionnaire (EHIS-PAQ)

    8-item questionnaire to assess time spent for work related physical activity, physical activity for transportation (walking, biking), muscle strengthening exercises and sports, fitness or recreational physical activity during a typical week.

    Measured: 1 week before start of the intervention (T0), 1 week after end of the intervention (T1)

  3. Würzburger Fatigue Inventory for MS (WEIMuS)

    This questionnaire contains 17 items that form a physical and cognitive subscale. The total score ranges from zero to a maximum of 68 points (maximum fatigue). The cut-off value for the presence of fatigue is above 32.

    Measured: 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)

  4. Allgemeine Depressionsskala (ADS-L)

    German version of the Center for Epidemiologic Studies Depression Scale, 20 item questionnaire. Each item is rated on a 4-point Likert scale. Answers are scored from 0 to 3. The scores for all items are added up to receive the total score. The total score ranges from 0 to 60 with higher scores representing higher levels of depression.

    Measured: 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)

  5. Multiple Sclerosis Walking Scale-12

    12-item questionnaire measuring self reported walking ability. Each item is answered on a 5-point Likert scale. Answers are scored from 1 to 5. The scores for all items are added up to receive a total score. The total score ranges from 12 to 60 with higher scores representing higher levels of depression. As a last step the total score is transformed into the walk12-score ranging from 0 to 100 ((total score -12)/48 x 100 = walk12-score).

    Measured: 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2019
  2. Study start28 Feb 2019
  3. Primary completion16 Aug 2019
  4. Study completion16 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04057066
Sponsor's protocol ID
ms bewegt 1.2
Status last verified
Apr 2020
First submitted
8 Aug 2019
Last updated
27 Apr 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Physical activity counseling and Exercise in people with Multiple Sclerosis, run by University of Erlangen-Nürnberg at 3 sites in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability of the Intervention and participants' experiences (focus groups) (time frame: 1 week after the end of the intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in